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SUMMARY
High-mobility group box 1 (HMGB1) is a deoxyribonucleic acid (DNA)-binding protein associated with DNA repair. Decreased nuclear HMGB1 expression and increased DNA damage response (DDR) were observed in human failing hearts. DNA damage and DDR as well as cardiac remodeling were suppressed in cardiac-specific HMGB1 overexpression transgenic mice after angiotensin II stimulation as compared with wild-type mice.
In vitro, inhibition of HMGB1 increased phosphorylation of extracellular signal-related kinase 1/2 and nuclear factor kappa B, which was rescued by DDR inhibitor treatment. DDR inhibitor treatment provided a cardioprotective effect on angiotensin II-induced cardiac remodeling in mice. H eart failure is a common disease and has been increasing worldwide (1, 2) . Despite advances in the treatment of heart failure, patients with heart failure are faced with a poor prognosis (3) . Cardiac remodeling, characterized by cardiac hypertrophy and fibrosis, is closely associated with the development of heart failure and death (4, 5) . It is well known that neurohumoral activation such as angiotensin II (Ang II) is one of the major risk factors for pathological cardiac remodeling and subsequent heart failure (6). However, treatment that is able to sufficiently suppress pathological cardiac remodeling has not been established yet.
High-mobility group box 1 (HMGB1) is an abundant chromatin-associated nuclear nonhistone binding protein, which has various functions in maintaining cellular homeostasis (7, 8) . HMGB1 translocates to extracellular from intracellular under various stress situations, and acts as a damage-associated molecular pattern (DAMP) that triggers several inflammatory responses (9, 10) . Extracellular HMGB1 was reported to cause cardiac hypertrophy and promote myocardial ischemia or reperfusion injury and inflammation (11) (12) (13) . In contrast, intracellular HMGB1 plays roles in maintaining nucleosome structure, regulating gene transcription, replication, and DNA repair (7, 8) .
Recently, it was reported that intracellular HMGB1 has a more important role in cell fate than extracellular HMGB1 during some inflammatory diseases since ablation of nuclear HMGB1 worsens disease condition (14) (15) (16) . We previously reported that cardiac nuclear HMGB1 prevents cardiomyocyte deoxyribonucleic acid (DNA) damage in a pressure overload heart failure mouse model (17) . However, the molecular mechanism underlying the antihypertrophic effect of cardiac nuclear HMGB1 has not been fully elucidated.
Various types of stress cause cellular DNA damage, and the DNA damage response (DDR) is induced immediately after DNA damage to repair it (18) . Activation of the DDR occurs after excessive DNA damage and is reported to be observed in end-stage failing human hearts (19) . Moreover, previous studies have revealed that DDR activation plays a crucial role in development of cardiac remodeling after myocardial infarction and cardiac hypertrophy (20, 21) .
We hypothesized that cardiac nuclear HMGB1 suppresses pathological cardiac remodeling through inhibition of DDR activation.
METHODS
A detailed description of all experimental procedures is provided in the Supplemental Appendix. n ¼ 6 in HMGB1-Tg saline group; n ¼ 6 in HMGB1-Tg Ang II group). As for ATM inhibitor experiments, the same parameters were also measured (n ¼ 9 in WT vehicle group; n ¼ 10 in WT Ang II þ vehicle group;
CELL CULTURE AND TREATMENT. Primary culture of neonatal rat cardiomyocytes (NRCMs) was performed as previously described (25, 26 (27) .
The expression of g-H2AX was also significantly .
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stimulation decreased the interaction between HMGB1 and ATM (Supplemental Figure 5C ).
Next, we analyzed the effect of HMGB1 on activation of the hypertrophic signaling pathway. HMGB1 overexpression significantly attenuated the phosphorylation of ERK1/2 and nuclear factor kappa B (NF-kB) induced by Ang II in NRCMs (Figures 6A and 6B ).
HMGB1 knockdown exhibited enhanced Ang II mediated activation of the ERK1/2 and NF-kB pathway ( Figures 6C and 6D) . We examined the effect of ATM on hypertrophic signaling kinases in NRCMs using a specific ATM inhibitor KU55933. Ang II-induced phosphorylation of ERK1/2 and NF-kB was reduced by treatment with an ATM inhibitor in NRCMs (Supplemental Figures 6A and 6B) . Furthermore, the enhanced phosphorylation of ERK1/2 and NF-kB by Ang II stimulation in HMGB1 knockdown NRCMs was suppressed by treatment with an ATM inhibitor ( Figure 6E ). We also evaluated the impact of nuclear HMGB1 and ATM on fetal cardiac gene expression.
Atrial natriuretic peptide (ANP) and BNP promoter activities were increased by Ang II stimulation in vitro (Supplemental Figures 7A and 7B ). HMGB1 knockdown exhibited enhanced ANP and BNP promoter activities induced by Ang II, which was abolished after pretreatment with ATM inhibitor (Figures 6F and 6G) . 
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Takahashi et al. protected against pressure overload induced heart failure and doxorubicin-induced cardiomyopathy (17, 25) . The protective roles of nuclear HMGB1 are further supported by the findings that ablation of nuclear HMGB1 worsens acute pancreatitis, liver ischemia and reperfusion injury, and bacterial infection (14, 15, 29) . Consistent with these studies, our results show the cardioprotective role of cardiac nuclear HMGB1 on pathological cardiac hypertrophy and fibrosis. Representative images and analysis of Western blots of p-ATM and total ATM. NRCMs transfected with siHMGB1 or nonspecific control siRNA and then treated with saline or Ang II for 24 h (n ¼ 3 per group). Results are presented as the mean AE SE. *p < 0.05; **p < 0.01; ***p < 0.001. Abbreviations as in Figures 1-4 .
The present study showed that cardiac nuclear These studies indicate the role of nuclear HMGB1 as a defender against cellular DNA damage in several disease conditions. In the heart, significantly more DNA damage was observed in heart failure patients compared with that of normal-health control subjects (19) . In the experimental model, DNA damage was also observed in a mouse model of myocardial infarction, which was associated with cell apoptosis (30) . Excessive DNA damage causes phosphorylation of ATM, a key regulator of DDR, and contributes to several disease conditions, including heart failure. Those effects were rescued by ATM deletion, and the ATM deletion prevented heart failure progression in mice, suggesting a causative role for ATM in heart failure (32) . These studies support the crucial role of ATMi ¼ ataxia telangiectasia mutated inhibitor; other abbreviations as in Table 1 .
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